Artificial Tears Reduce Dryness Symptoms in 1-Month Study
Conexiant
March 24, 2026
A preservative-free artificial tear formulation significantly reduced ocular dryness symptoms after 1 month in a multicenter study in Spain.
Patients using Systane Complete Preservative-Free eye drops showed improved OSDI scores from 23 at baseline to 8 at 1 month.
Mean DEQ-5 scores decreased from 10 to 4, indicating symptom improvement, particularly pronounced at the final visit.
Objective signs of ocular dryness, including conjunctival and limbal hyperemia, also improved significantly during the study.
The study had limitations, including no control group and a predominance of women, with exploratory findings on environmental factors.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Affiliations:
Specialties:
Areas of Expertise: